Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Market Estimate
Information Sources

• Primary Research
• Secondary Research

Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Introduction to Nanoparticles

• Liposomes
• Quantum Dots
• Dendrimers

Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drug Revenues

Chapter 4 Market Breakdown by Product Type

Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Distribution of Nanobiotechnology and Nanomedicine Companies

Chapter 5 Structure of Nanoparticles

Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered

Chapter 6 Production of Nanoparticles

Methods of Nanoparticle Formation

• Self-Assembly Production
• Methods of Stabilization

Methods of Drug Introduction

• Polymeric Nanoparticles
• Micelles
• Liposomes
• Gold and Silicon Nanoparticles
• Dendrimers

Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticles Production

Chapter 7 Nanoparticles in Biotechnology

Research and Development

• Stem Cell Research
• Cellular Repair
• Paramagnetic and Superparamagnetic Nanoparticles
• Biosensors and Quantum Dots

Nanoparticle Research Collaborative Programs

Chapter 8 Nanoparticles in Drug Development and Formulation

Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs

Chapter 9 Nanoparticles in Drug Delivery Systems

Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System

• Nanoparticle Drug Stability
• Size Homogeneity of Nanoparticle Preparations
• Drug Loading of Nanoparticles
• Drug Release from Nanoparticles
• External Triggers for Releasing Drugs from Nanoparticles
• Binding/Incorporation of Biomolecules to Nanoparticles
• Nanoparticle Toxicity
• Large Scale Manufacturing

Methods of Administration of Nanoparticle Drugs

• Oral Administration
• Injection Administration
• Transdermal Patch
• Implantation Administration
• Inhalation Administration
• Nanoparticles Suitable for Drug Delivery Systems
• Lipid-Based Nanoparticles
• Micelle Nanoparticles
• Dendrimer Nanoparticles
• Polymeric Nanoparticles
• Metal-Based Nanoparticles
• Biological Macromolecule Nanoparticles
• Nanocrystals

Nanoparticle Drug Delivery Systems Now Available

• Antibiotic Nanoparticles
• Anti-Tumor and Small Molecule Delivery by Nanoparticle
• Release of Anti-Cancer Drugs from Nanoparticles
• Biomacromolecules Delivered by Nanoparticles
• Nanoparticles Coating for Drug Delivery Systems
• Removal of Nanoparticles from the body

Chapter 10 In Vitro and In Vivo Diagnostic Imaging

In Vitro Imaging
Nanoparticles in Diagnostic Imaging

Chapter 11 Biomedical Nanoparticle Products

Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing

Chapter 12 Market Breakdown by Region

Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World

• South America
• Middle East and Africa

Chapter 13 Role of Nanotechnology in COVID-19 Vaccine Production

Introduction
Novel Coronavirus Relying on Various Approaches
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines

• Antigen
• Adjuvant
• Nanoparticle/Nanocarrier
• Device

Next Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Usage Against COVID-19

Chapter 14 Patents, Licensing, Mergers and Acquisitions

Recent Licensed, Mergers and Acquisition
Recent Licensing Activity, Mergers and Acquisition
Recent Deals
Nanoparticle Patents

Chapter 15 Company Profiles

BRISTOL-MYERS SQUIBB CO.
CAMURUS AB
CERAMISPHERE PTY LTD.
CYTIMMUNE SCIENCES
GLAXOSMITHKLINE PLC.
HOFFMANN-LA ROCHE INC.
MERCK & CO. INC.
NANOCARRIER CO. LTD.
NOVARTIS AG

List of Tables

Summary Table : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, Through 2025
Table 1 : Description of Nanoparticles Used in Drug Delivery and Diagnostic Imaging
Table 2 : Applications of Nanoparticles in Biotechnology
Table 3 : Applications of Nanoparticles in Drug Development
Table 4 : Applications of Nanoparticles in Drug Delivery Systems
Table 5 : Nanoparticles Used in Drug Delivery Systems
Table 6 : Nanoparticles Used for In vivo Diagnostic Imaging
Table 7 : Major Players in Nanoparticle Drug Field
Table 8 : Major Nanoparticle/Nanocrystal Drug by Product and Company
Table 9 : Global Market for Nanoparticles in Biotechnology, Through 2025
Table 10 : Global Market for Nanoparticles in Drug Development and Formulation, Through 2025
Table 11 : Global Market for Nanoparticles in Drug Delivery Systems, Through 2025
Table 12 : Global Market for Nanoparticles in Diagnostic Imaging Systems, Through 2025
Table 13 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
Table 14 : Nanoparticles Structure and Properties
Table 15 : Nanoparticles Systems Approved for Drug Delivery
Table 16 : Sample of Drugs Delivered Through Liposome Nanotechnology
Table 17 : Nanoparticles in Biotechnology Applications
Table 18 : Nano Biosensor Technology Under Development
Table 19 : ETPN Strategic Research and Innovation Agenda
Table 20 : Nanoparticles in Drug Development Applications
Table 21 : Monoclonal antibody (mAb) Drugs with Potential for Use in Nanoparticles Delivery Systems
Table 22 : Solid Lipid Nanoparticles-Reformatted Drugs
Table 23 : Nanoparticles in Drug Delivery Applications
Table 24 : Standard Routes of Drug Administration
Table 25 : Nanoparticle Transdermal Patch Products
Table 26 : Type of Nanoparticles Supplied in Drug Delivery Systems
Table 27 : Mechanism for Removal of Nanoparticles from the Body
Table 28 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 29 : List of Marketed Products Used in Different Nanotechnology-based Techniques
Table 30 : Major Players in Nanoparticle Drug Development and Formulation Market
Table 31 : Company Pipeline for Cardiovascular Nanoparticle Drugs
Table 32 : Company Pipeline for CNS Disease Nanoparticle Drugs
Table 33 : Company Pipeline for GI Disease Nanoparticle Drugs
Table 34 : Company Pipeline for Infectious Disease Nanoparticle Drugs
Table 35 : Company Pipeline for Cancer Nanoparticle Drugs
Table 36 : Company Pipeline for Ophthalmic Nanoparticle Drugs
Table 37 : Company Pipeline for Autoimmune Disease Nanoparticle Drugs
Table 38 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Region, Through 2025
Table 39 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
Table 40 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
Table 41 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
Table 42 : Global Nanotechnology, Patents, by Country, 2017-2020
Table 43 : Bristol-Myers Squibb Co.: Financials, 2017-2019

List of Figures

Summary Figure : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, 2019-2025
Figure 1 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 2 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019-2025
Figure 3 : Global Market Share for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019
Figure 4 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 5 : North American Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
Figure 6 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 7 : European Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
Figure 8 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 9 : Asia-Pacific Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
Figure 10 : South American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 11 : Middle Eastern and African Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025

当レポートのプレスリリースは発行されておりません。